Neurometrix Stock Price Prediction
| NURO Stock | USD 4.33 0.68 18.63% |
Oversold Vs Overbought
48
Oversold | Overbought |
NeuroMetrix stock price prediction is an act of determining the future value of NeuroMetrix shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of NeuroMetrix's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of NeuroMetrix and does not consider all of the tangible or intangible factors available from NeuroMetrix's fundamental data. We analyze noise-free headlines and recent hype associated with NeuroMetrix, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting NeuroMetrix's stock price prediction:Wall Street Target Price 50 | Quarterly Revenue Growth (0.29) |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of NeuroMetrix based on different types of headlines from major news networks to social media. The NeuroMetrix stock price prediction module provides an analysis of price elasticity to changes in media outlook on NeuroMetrix over a specific investment horizon. Using NeuroMetrix hype-based prediction, you can estimate the value of NeuroMetrix from the perspective of NeuroMetrix response to recently generated media hype and the effects of current headlines on its competitors.
This module is based on analyzing investor sentiment around taking a position in NeuroMetrix. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in NeuroMetrix to buy its stock at a price that has no basis in reality. In that case, they are not buying NeuroMetrix because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
NeuroMetrix after-hype prediction price | USD 4.58 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
NeuroMetrix |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NeuroMetrix's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NeuroMetrix After-Hype Price Prediction Density Analysis
As far as predicting the price of NeuroMetrix at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in NeuroMetrix or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of NeuroMetrix, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
NeuroMetrix Estimiated After-Hype Price Volatility
In the context of predicting NeuroMetrix's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on NeuroMetrix's historical news coverage. NeuroMetrix's after-hype downside and upside margins for the prediction period are 0.23 and 9.53, respectively. We have considered NeuroMetrix's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
NeuroMetrix is somewhat reliable at this time. Analysis and calculation of next after-hype price of NeuroMetrix is based on 3 months time horizon.
NeuroMetrix Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as NeuroMetrix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NeuroMetrix backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with NeuroMetrix, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.73 | 4.95 | 0.25 | 1.95 | 10 Events / Month | 5 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
4.33 | 4.58 | 5.77 |
|
NeuroMetrix Hype Timeline
NeuroMetrix is now traded for 4.33. The entity has historical hype elasticity of 0.25, and average elasticity to hype of competition of -1.95. NeuroMetrix is projected to increase in value after the next headline, with the price projected to jump to 4.58 or above. The average volatility of media hype impact on the company the price is over 100%. The price boost on the next news is projected to be 5.77%, whereas the daily expected return is now at 0.73%. The volatility of related hype on NeuroMetrix is about 185.57%, with the expected price after the next announcement by competition of 2.38. NeuroMetrix currently holds about 20.83 M in cash with (6.08 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.68. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out NeuroMetrix Basic Forecasting Models to cross-verify your projections.NeuroMetrix Related Hype Analysis
Having access to credible news sources related to NeuroMetrix's direct competition is more important than ever and may enhance your ability to predict NeuroMetrix's future price movements. Getting to know how NeuroMetrix's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how NeuroMetrix may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| A | Agilent Technologies | 1.40 | 9 per month | 1.44 | (0.02) | 2.26 | (2.44) | 6.31 | |
| ILMN | Illumina | 2.01 | 10 per month | 0.00 | (0.12) | 3.65 | (3.83) | 9.89 | |
| WAT | Waters | 1.35 | 11 per month | 0.00 | (0.07) | 2.55 | (3.04) | 7.95 | |
| TMO | Thermo Fisher Scientific | (4.99) | 8 per month | 1.28 | (0.05) | 1.80 | (1.63) | 6.87 | |
| MTD | Mettler Toledo International | (18.65) | 7 per month | 1.82 | (0.03) | 2.48 | (3.26) | 6.80 | |
| CRL | Charles River Laboratories | (2.39) | 9 per month | 1.57 | 0.05 | 2.87 | (2.57) | 15.05 | |
| GH | Guardant Health | (0.35) | 11 per month | 0.00 | (0.13) | 5.82 | (7.29) | 22.73 | |
| RVTY | Revvity | 0.28 | 12 per month | 0.00 | (0.11) | 2.09 | (3.33) | 8.67 |
NeuroMetrix Additional Predictive Modules
Most predictive techniques to examine NeuroMetrix price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for NeuroMetrix using various technical indicators. When you analyze NeuroMetrix charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About NeuroMetrix Predictive Indicators
The successful prediction of NeuroMetrix stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as NeuroMetrix, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of NeuroMetrix based on analysis of NeuroMetrix hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to NeuroMetrix's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to NeuroMetrix's related companies. | 2023 | 2024 (projected) | Dividend Yield | 20.92 | 21.96 | Price To Sales Ratio | 0.64 | 0.6 |
Story Coverage note for NeuroMetrix
The number of cover stories for NeuroMetrix depends on current market conditions and NeuroMetrix's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that NeuroMetrix is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about NeuroMetrix's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
NeuroMetrix Short Properties
NeuroMetrix's future price predictability will typically decrease when NeuroMetrix's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of NeuroMetrix often depends not only on the future outlook of the potential NeuroMetrix's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. NeuroMetrix's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1 M | |
| Cash And Short Term Investments | 18 M |
Check out NeuroMetrix Basic Forecasting Models to cross-verify your projections. To learn how to invest in NeuroMetrix Stock, please use our How to Invest in NeuroMetrix guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Complementary Tools for NeuroMetrix Stock analysis
When running NeuroMetrix's price analysis, check to measure NeuroMetrix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NeuroMetrix is operating at the current time. Most of NeuroMetrix's value examination focuses on studying past and present price action to predict the probability of NeuroMetrix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NeuroMetrix's price. Additionally, you may evaluate how the addition of NeuroMetrix to your portfolios can decrease your overall portfolio volatility.
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |
Is NeuroMetrix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NeuroMetrix. If investors know NeuroMetrix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NeuroMetrix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (6.27) | Revenue Per Share 5.664 | Quarterly Revenue Growth (0.29) | Return On Assets (0.19) | Return On Equity (0.30) |
The market value of NeuroMetrix is measured differently than its book value, which is the value of NeuroMetrix that is recorded on the company's balance sheet. Investors also form their own opinion of NeuroMetrix's value that differs from its market value or its book value, called intrinsic value, which is NeuroMetrix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NeuroMetrix's market value can be influenced by many factors that don't directly affect NeuroMetrix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NeuroMetrix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NeuroMetrix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NeuroMetrix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.